Introduction
Medulloblastoma is an embryonal tumor arising from cerebellar granule neuron precursors (CGNPs), and it is the most common brain malignancy in children (reviewed by Raffel, 2004) . Despite multimodal therapy that includes surgery, radiation and chemotherapy, its poor prognosis has not improved significantly in the last two decades (MacDonald et al., 2003) . Improvements in therapy will benefit greatly by the identification of genes and biological pathways that contribute to medulloblastoma development.
The Shh pathway is a major regulator of cerebellar development, since Shh secreted by Purkinje cells promotes proliferation of CGNPs in the external granule layer (EGL) (Dahmane and Ruiz-i-Altaba, 1999; Wallace, 1999; Wechsler-Reya and Scott, 1999) . A subset of hereditary and sporadic medulloblastomas show mutation in one copy of Patched (Ptc1) (Hahn et al., 1996; Raffel et al., 1997; Zurawel et al., 2000a) , which encodes a cell surface Shh-receptor and negative regulator of the pathway. This suggests that uncontrolled activation of this mitogenic pathway, that has a pivotal role in cerebellar ontogenesis, leads to medulloblastoma formation.
Insights for medulloblastoma tumorigenesis arise from recently developed animal models. In the mouse, deletion of one Ptc1 allele results in spontaneous medulloblastoma development, underlying the critic tumorigenic role of Ptc1 as a key modulator of signalling in the Shh pathway (Goodrich et al., 1997; Hahn et al., 1998) . Various combinations of targeted deletions in genes controlling cell cycle checkpoints, apoptosis and DNA repair, such as Ptc1, Rb, DNA Ligase IV, PARP-1 and Ink4c in combination with p53 loss also result in murine medulloblastoma (Marino et al., 2000; Wetmore et al., 2001; Lee and McKinnon, 2002; Pazzaglia et al., 2002; Tong et al., 2003; Zindy et al., 2003) . While these models are informative, simultaneous mutations in these pathways are rare in human medulloblastoma. An alternative approach is to complement Ptc1 mutation with ionizing radiation. DNA damage induced by radiation strongly promotes medulloblastoma development in newborn Ptc neo67/ þ mice in which the EGL is still proliferating (Pazzaglia et al., 2002) . Since the quasi-totality of neurogenesis from the EGL is neonatal, and occurs during the first 2 weeks of postnatal life in mice, here we have further investigated the age-dependence of susceptibility by irradiating Ptc neo67/ þ mice at P1 and P10. Our data show a striking enhancement of medulloblastoma by irradiating mice at P1, compared to no enhancement after irradiation at P10. This indicates that the period of granule cell competence in which radiation-induced stochastic events required for medulloblastoma tumorigenesis may take place in a setting of Shh pathway deregulation is very limited and ends within P10. To elucidate the mechanisms of age-dependent susceptibility of the cerebellum to medulloblastoma induction, we have characterized the apoptotic response to radiation of P1 and P10 cerebellum in Ptc1 mutant mice. We present data to show that medulloblastoma formation is associated with CGNPs resistance to radiation-induced cell killing, regulated by the dynamic interplay of p53 and the cell survival-promoting Akt/ protein kinase B (Pkb).
Results
Survival and tumorigenesis after X-ray irradiation of newborn Ptc neo67/ þ mice at P1 and P10 The survival of Ptc neo67/ þ heterozygous mice irradiated at P1 or P10 is reported in Figure 1 . A striking increase in mortality was observed in Ptc neo67/ þ heterozygous mice irradiated at P1 (Figure 1a ). By 36 weeks of age, none of these mice had survived compared to 36% of mice irradiated at P10 (Po0.0001), confirming that survival is strongly dependent on mouse age at irradiation. For comparison, the survival curve of mice irradiated at P4 is reported from a previous publication (Pazzaglia et al., 2002) .
The cumulative tumor incidence was 100% in mice irradiated at P1 compared to 85% in mice irradiated at P10. This difference, however, was not statistically significant. Life shortening of mice irradiated at P1 was mainly due to development of medulloblastomas, which represented the major cause of death with an incidence of 81% (Figure 1b) . In this group, medulloblastoma showed a very short latency, developing between 7 and 20 weeks postirradiation. There was a large difference between medulloblastoma incidence in mice irradiated at P1 (81%) and the incidence previously observed in mice irradiated at P4 (51%) (Pazzaglia et al., 2002) (P ¼ 0.0330), and a striking difference with the incidence observed in mice irradiated at P10 (3%) (Po0.0001), indicating that the ability of ionizing radiation to synergize with Ptc1 mutation to promote medulloblastoma formation decreases very sharply as neurogenesis progresses. The incidence of medulloblastoma in mice irradiated at P10 was similar to that of unirradiated controls (6.7%), suggesting the existence of a short timewindow of radiosensitivity. The predominant tumor type in mice irradiated at P10 was soft tissue sarcoma, which developed in 42% of mice, an incidence very similar to that of unirradiated Ptc neo67/ þ heterozygotes (40%). In contrast, mice irradiated at P1 did not develop soft tissue sarcomas -that have a late onset -due to early mortality for medulloblastoma. No further significant difference in tumor incidence and spectrum was observed between mice irradiated at P1 or P10 (Figure 1c ).
Cerebellar hyperproliferation of granule neurons after irradiation at P1 and P10 Figure 2 shows H&E-stained sagittal sections of cerebella from unirradiated Ptc neo67/ þ mice at P1 and P10 (a and b), and proliferating CGNPs, detected by BrdU incorporation, in P1 and P10 cerebellum ( Figure  2c and d). While BrdU incorporation was evident Figure 1 Mortality and medulloblastoma incidence of Ptc neo67/ þ mice irradiated with 3 Gy of X-rays at P1 or P10. (a) High mortality was observed in P1-compared to P10-irradiated mice. (b) A 81% medulloblastoma incidence was observed in P1-compared to 3% in P10-irradiated mice. Survival and medulloblastoma incidence in Ptc neo67/ þ mice irradiated at P4 are reported for comparison (Pazzaglia et al., 2002) . (c) Tumor spectrum in Ptc neo67/ þ mice irradiated at P1 or P10.
Medulloblastoma in Ptc neo67/ þ mice S Pazzaglia et al through the entire EGL at P1 (Figure 2c) , it was clearly restricted to the proliferative EGLa outer compartment at P10 (Figure 2d) .
A further important feature of the cerebellum of Ptc neo67/ þ mice at 3 weeks was the presence of abnormal cerebellar EGL regions ranging from small areas of hyperproliferation of granule neurons to overt nodules ( Figure 3a-d) ; these abnormalities were present in both control and irradiated mouse cerebella, although with different frequencies (Figure 3e ). In unirradiated Ptc neo67/ þ mice these lesions were evident in 3/5 (60%) mice at P21 and 3/5 (60%) at P31 (Figure 3e ). However, only 7% of unirradiated mice developed medulloblastomas, indicating that only a subset of hyperproliferating areas progress to medulloblastoma. Most of these spontaneous lesions will regress by adulthood, since they are not detected in mice autopsied at later times (data not shown). The frequency of these areas increased to 100% (6/6) in cerebellum irradiated at P1, but was only 14% (1/7) after irradiation at P10 (Figure 3e ). This suggests that irradiation of the cerebellum at P10 accelerated regression of these lesions, probably through a mechanism of cell killing.
Apoptotic response to ionizing radiation of Ptc neo67/ þ cerebellum at P1 and P10 To investigate the mechanisms of different susceptibility to radiation-induced medulloblastoma tumorigenesis of Ptc neo67/ þ mouse cerebellum of different developmental stages, we examined the apoptotic response to radiationinduced DNA damage in P1 and P10 mice (Figure 4a and b). Quantitation of pyknotic nuclei in the EGL of irradiated cerebellum revealed widespread cell death in both Ptc neo67/ þ heterozygous and wt mice, with no significant difference (wt is not shown). Cell death induced by 3 Gy of X-rays was 2.5-fold lower in the cerebellum of P1 compared to P10 Ptc neo67/ þ heterozygotes 3 h after irradiation (8.9% apoptotic cells versus 20.0%) (Figure 4c ). This difference was reduced to 1.3-fold 6 h after irradiation (36.7% apoptotic cells versus 49.5%). Differences in cell death between P1 and P10 mice were highly statistically significant (Po0.001) at both postirradiation times analysed.
Results of cell death assay led us to hypothesize that radiation might activate caspase-dependent apoptotic pathways. Thus, we investigated the expression of active caspase-3 in the cerebellum of mice irradiated at P1 or One of the essential substrates cleaved by caspase-3 is poly (ADP-ribose) polymerase (PARP). Cleavage of the entire 116-kDa PARP protein into two fragments of 85 and 26 kDa has been considered indicative of functional caspase-3 activation. We used Western blot analysis to determine generation of caspase-3-cleaved PARP in the cerebellum of P1 and P10 mice at 3 and 6 h after irradiation with 3 Gy of X-rays ( Figure 4f ). Our results show 2.2 (3 h) and 1.7-fold (6 h) increased intensity of the 85 kDa PARP antibody band corresponding to the major PARP fragment in P10-compared to P1-irradiated cerebellum (Figure 4g ).
P53 expression in P1 or P10 cerebellum following irradiation
Since the p53 gene product is required for radiationinduced apoptosis in cerebellar granule neurons (Wood and Youle, 1995) , we characterized immunohistochemically the p53 pattern of expression after radiation exposure. We show a dramatic difference in p53 expression in the EGL between cerebellum of mice irradiated at P1 or P10 (Figure 5a and b) . While a strong p53 expression was detected in the cerebellum irradiated at P10 (Figure 5b ), lack of detectable p53 expression was shown in the cerebellum irradiated at P1 (Figure 5a ).
Western blot analysis was used to determine p53 protein levels in the cerebellum after irradiation with 3 Gy of X-rays ( Figure 5c ). As shown in Figure 5d , a sevenfold lower protein level was observed in the cerebellum of mice irradiated at P1 compared to mice irradiated at P10. This difference was reduced to 1.6-fold 6 h after irradiation, as a result of consistent increase in p53 protein level in the cerebellum irradiated at P1, and of concurrent sharp decrease after irradiation at P10. These findings indicate a significant delay and a consistent decrease in the activation of p53 in response to cellular stress induced by radiation in cerebellum of mice at P1. As expected, p53 protein was undetectable in unirradiated P1 and P10 cerebellum (not shown).
Activation of the phosphatidylinositide 3
0 -OH kinase (PI3K)-Akt/Pkb pathway in P1 and P10 cerebellum We asked whether activation of PI3K-Akt/Pkb pathway is involved in lack of p53 accumulation in the mouse cerebellum irradiated at P1. Thus, we performed Western blot analysis to determine total and pS437 Akt/Pkb protein levels in the cerebellum of unirradiated and irradiated mice (Figure 5e ). In unirradiated cerebella, we observed a very large difference in Akt/ Pkb phosphorylation status between P1 and P10 mice (Figure 5f ). In fact, 100% of phosphorylated Akt/Pkb was observed at P1 compared to about 50% at P10. Interestingly, irradiation decreased the expression of pS473 Akt, which was reduced to 47% in P1-and 13% in P10-irradiated cerebellum 3 h after irradiation. The 
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Akt/Pkb phosphorylation status analysed 6 h after irradiation remained substantially unchanged in P1-, while it returned to the level of unirradiated controls in P10-irradiated cerebellum.
Allelic imbalance analysis at the Ptc1 locus in medulloblastomas Loss of the wt Ptc1 allele was examined in medulloblastomas. This was performed by discriminating the nucleotide sequence of the targeted Ptc1 allele -derived from 129Sv ES cells -from the sequence of the wt allele -derived from CD1 mice -based on the presence of a polymorphism (T/C) in position 4016 of the Ptc1 gene (Calzada-Wack et al., 2002) . Sequence analysis of cDNA (two samples) showed expression of the 129Sv-derived mutant allele and lack of expression of the CD1-derived wt mRNA in radiation-induced medulloblastomas from Ptc neo67/ þ mice. In agreement, sequence analysis of genomic DNA (seven samples) from radiation-induced medulloblastomas showed lack of the CD1 wt Ptc1 sequence (Figure 6a ). This indicates that mutation rather than epigenetic silencing was responsible of Ptc1 loss of function in medulloblastomas. In contrast, amplification of genomic DNA from normal tissue of Ptc neo67/ þ heterozygotes showed the presence of both Ptc1 alleles (Figure 6b ).
Discussion
Ionizing radiation synergize with Ptc1 mutation to induce medulloblastoma at high incidence. The underlying molecular events, however, remain unclear. Induction of medulloblastoma by radiation in Ptc neo67/ þ mice offers the advantage of controlled timing of DNA damage induction, and allows in vivo analysis of early alterations in cerebellar signalling that can help to clarify the steps of the tumorigenic process from initial gene deregulation to medulloblastoma development.
In this study, we have identified a narrow timewindow of radiosensitivity in Ptc neo67/ þ cerebellum, since even small age-differences at the time of irradiation produced drastic changes in medulloblastoma tumorigenesis. Medulloblastoma incidence, in fact, ranged from 81 to 3% after irradiation at P1 or P10. A striking difference was also observed in the frequency of Marked enhancement of hyperproliferation areas was obtained after irradiation at P1, as opposed to drastic suppression at P10. Difference in frequency of hyperproliferative lesions between mice irradiated at P1 or P10 (100 versus 14%) was highly statistically significant (P ¼ 0.0047).
We reported previously a strong enhancement of medulloblastoma (51%) after irradiation of neonatal Ptc neo67/ þ mice at P4, as opposed to lack of enhancement by irradiating adult Ptc neo67/ þ mice (Pazzaglia et al., 2002) . In view of the well-known higher radiosensitivity of younger actively dividing cells in very early postnatal cerebellum compared to postmitotic cells in older rodents (Anderson and Stromberg, 1977; Cerda, 1983) , we correlated the ability of radiation to induce medulloblastoma in neonatal age with the rapid expansion of CGNPs from which medulloblastoma originates. However, here, we present evidence that irradiation of Ptc neo67/ þ mice at P10 fails to induce medulloblastoma despite evident ongoing proliferation in P10-cerebellum, shown by BrdU incorporation in CGNPs of the EGL (Figure 2d ). These observations suggest that additional factors influence CGNPs susceptibility to neoplastic transformation.
Interestingly, lower incidences of hyperproliferation areas (14 versus 60%) were detected in mice irradiated at P10 compared to untreated mice. This observation implies that irradiation of P10-cerebellum is not only unable to initiate new lesions, but it also exerts a strong cell killing effect on the existing spontaneous lesions. Consistent with this observation, cellular and biochemical investigation of radiation-induced apoptotic response of cerebellar neurons at P1 and P10 showed that the number of pyknotic nuclei, and the expression of active caspase-3 and of cleaved PARP are substantially lower in CGNPs of P1-compared to P10-irradiated mice, thus revealing development-related differences between the overall levels of cell death in response to ionising radiation. Moreover, these results suggest that medulloblastoma formation in Ptc1 mutants may be associated with resistance to radiationinduced cell killing.
A number of studies have shown that radiationinduced cell death in the developing nervous system is p53-dependent (Wood and Youle, 1995; Enokido et al., 1996; Herzog et al., 1998; Johnson et al., 1998) . To clarify the molecular mechanisms responsible of the different response to radiation of CGNPs in P1-and P10-cerebellum, we investigated the expression of p53. In normal unstressed cells, p53 is an unstable protein with a half-life of less than 20 min, and it is kept at very low levels owing to continuous degradation. Immunohistochemical analysis showed that p53 induction after irradiation is mostly localized to the EGL (Figure 5a and b), the same region that undergoes apoptosis in response to genotoxic stress, suggesting that the apoptotic process occurring in irradiated cerebellum is largely driven by activation of p53. Moreover, immunoblot and immunohistochemical analysis showed a drastically decreased level of p53 in P1-compared to P10-irradiated cerebellum (Figure 5a-d) . Our data show an association between the delayed and decreased p53 expression and the resistance to radiation-induced cell killing observed in CGNPs at P1.
Having shown that there is increasing radiationinduced apoptosis as cerebellar development progresses, we focused on the PI3K-Akt/Pkb pathway, which is a critical mediator of neuronal survival (Dudek et al., 1997) . We found that the level of phosphorylation of Akt at residue S437, essential for its full activation, is considerably higher in both unirradiated and irradiated cerebellum at P1 than in corresponding cerebellum at P10, thus suggesting that Akt/Pkb activation may be critical for regulation of the balance between cell death and survival. The inverse correlation between the levels of phosphorylated Akt/Pkb and p53 in irradiated cerebellum supports a regulatory interaction between the PI3K-Akt/Pkb pathway and p53, as also suggested by prior reports (Buckbinder et al., 1995; Singh et al., 2002) .
Different levels of activated Akt/Pkb in P1 and P10 cerebellum may reflect variations in insulin-like growth factors (IGFs). These widely expressed factors are temporally and spatially distributed in the CNS, as they play a significant role in the stimulation of brain development . IGF-I predominantly expressed in neuronal cells, has been reported to protect CGNPs from apoptosis via PI3K and Akt/Pkb (Dudek et al., 1997) and transgenic mice overexpressing IGF-I, exhibit a doubling of CGNPs number and show decreased expression of caspase-3 in cerebellum Chrysis et al., 2001) . IGF-II, mainly restricted in non-neuronal cells (meningies and choroids Medulloblastoma in Ptc neo67/ þ mice S Pazzaglia et al plexus), has been strictly involved in Shh-dependent tumor formation. Deletion of the Igf2 gene, in fact, completely eliminates medulloblastoma and rhabdomyosarcoma development in Ptc neo67/ þ /Igf2 double knockout mice (Hahn et al., 2000) , and coexpression with IGF2 or Akt/Pkb strongly enhances the effect of Shh-induced medulloblastoma formation in mice (Rao et al., 2004) . This suggests a synergy between the Shh and PI3K pathways in Shh/Ptc1-associated tumorigenesis.
While it was initially proposed that loss of one Ptc1 allele was sufficient for medulloblastoma formation in mice (Wetmore et al., 2000; Zurawel et al., 2000b) , recent reports suggest that Ptc1 expression is drastically reduced or lacking in medulloblastomas (Berman et al., 2002; Tong et al., 2003) . To analyse this issue, allelic imbalance at the Ptc1 locus was examined in cDNAs and DNAs from radiation-induced medulloblastomas. In agreement with our previous results (Pazzaglia et al., 2002) , we show that all tumors are characterized by loss of the remaining wt Ptc1 allele, confirming loss of Ptc1 function as a key event in radiation-induced medulloblastoma tumorigenesis.
Double-strand break (DSB) repair involving homologous chromosomes in mitotically dividing cells is a potential mechanism leading to loss of heterozygosity (LOH) (Stark and Jasin, 2003) . In view of the recently proposed additional role for the p53 protein as a suppressor of homologous recombination (HR) (Sturzbecher et al., 1996; Linke et al., 2003; Sengupta et al., 2003) , and based on evidences showing that functional inactivation of wt p53 results in elevated HR rates (Saintigny and Lopez, 2002; Blackburn et al., 2004) , we speculate a role of mitotic recombination (MR) as a pathway to LOH in our tumors. Decreased p53 expression in P1 cerebellum may, in fact, promote DSB repair by MR. In line with this hypothesis, p53 loss has been shown to dramatically accelerate the age of onset and incidence of medulloblastoma in Ptc1 heterozygotes; 95% of the Ptc1
À/À mice developed medulloblastomas by 12 weeks of age (Wetmore et al., 2001) . Experiments aimed to test the contribution of DNA damage signalling and repair in medulloblastoma formation are in progress.
In summary, we have shown that the response of the cerebellum to ionizing radiation exposure depends on developmental stage, as demonstrated by the very large difference in medulloblastoma incidence, frequency of cerebellar preneoplastic lesions and apoptotic response between P1 and P10 cerebellum. Notably, this agedependence cannot be ascribed to obvious differences in the proliferation status of CGNPs at the two postnatal ages. Moreover, we have shown that susceptibility to medulloblastoma induction and marked resistance to radiation-induced cell death observed at P1 are associated with p53 inhibition and Akt/Pkb activation in CGNPs. In contrast, resistance of P10-cerebellum to medulloblastoma induction is associated with susceptibility to radiation-induced cell death, probably mediated by strong p53 expression and lower Akt/Pkb activity.
This study helped to elucidate the in vivo molecular mechanisms involved in Ptc1-associated susceptibility to radiation induced medulloblastoma tumorigenesis from early radiation response of CGNPs to acquisition of overt malignancy, providing insights into cerebellar signalling implicated in the pathogenesis of one of the most deadly childhood tumors.
Materials and methods

Mice
Mice lacking one Ptc1 allele, generated through disruption of exons 6 and 7 in 129/SV ES cells, and maintained on a CD1 background were used for this study. Ptc neo67/ þ mice were genotyped using PCR primers specific to the neo insert and wt regions as described (Hahn et al., 1998) . Animals were housed under conventional conditions with food and water available ad libitum and a 12-h light cycle. Experimental protocols were reviewed by the Institutional Animal Care and Use Committee.
Irradiation X-ray irradiation was performed using a Gilardoni CHF 320 G X-ray generator (Gilardoni S.p.A., Mandello del Lario, Lecco, Italy) operated at 250 kVp, 15 mA, with filters of 2.0 mm Al and 0.5 mm Cu (HVL ¼ 1.6 mm Cu). For tumorigenesis experiments, 21 Ptc neo67/ þ heterozygous mice and 20 wt littermates were irradiated at P1; 33 Ptc neo67/ þ and 24 wt littermates were irradiated at P10. The X-ray dose was 3 Gy for all groups.
Histological analysis and tumor quantification Mice were observed daily for their whole life span. Upon decline of health (i.e., severe weight loss, paralysis, ruffling of fur or inactivity) or when tumors were visible, they were killed and autopsied. Whole brain and any other visible mass were partly fixed in 4% buffered formalin and partly snap frozen. Samples were then embedded in paraffin wax, sectioned and stained according to standard techniques.
Tumor incidence was expressed as the percentage of mice with one or more tumors. Incidence of microscopic cerebellar lesions was determined on asymptomatic Ptc neo67/ þ heterozygous mice irradiated with 3 Gy of X-rays at P1 or P10 and sacrificed 3 weeks post irradiation, and on age-matching unirradiated mice. Five to seven mouse brains were collected at each time point. In all, 24 sections were examined for each cerebellum: to ensure a representative sampling, each set of sections (n ¼ 8) in an individual slide was recovered with an interval of 70 mm.
Radiosensitivity analysis
Brains (two per time point) of Ptc1 heterozygous pups irradiated with 3 Gy of X-rays at P1 or P10 were collected at 3 and 6 h postirradiation and fixed in 4% buffered formalin. Serial sections of cerebellar tissues were cut at 5-mm thickness and stained with H&E. In all, 13-15 digital images/mouse from midsagittal cerebellar sections of P1 pups, covering the entire cerebellar surface, and 25 digital images/mouse from P10 pups, covering most of the cerebellar surface, were collected by IAS image-processing software (Delta Sistemi, Rome, Italy). Cells showing signs of nuclear chromatin condensation and morphologically normal cells in the EGL were counted using a double-blind method. Apoptotic values were calculated as the percentage pyknotic nuclei relative to the total number of cells. Approximately 5 Â 10 3 or 10 4 cells were examined for each time point in the EGL of P1 and P10 cerebellum, respectively.
Antibodies
Antibodies included rabbit polyclonal antibody against activecaspase-3 (Santa Cruz Biotechnology, Santa Cruz, CA, USA); rabbit polyclonal antibody against p53 (Novocastra Laboratories, Newcastle, UK); monoclonal antibody against PARP (Trevigen, Gaithersburg, MD, USA); rabbit polyclonal antibodies against phospho-Akt (Ser473) and total Akt (Cell Signaling, Beverly, MA, USA); monoclonal antibody against b-actin (Sigma-Aldrich Inc., St Louis, MO, USA).
Immunohistochemistry and immunoblotting
We carried out immunohistochemical analysis on cerebellum sections as previously described (Mancuso et al., 2004) . For immunoblotting, we normalized total cell extracts for protein concentration (Bradford assay, Bio-Rad Laboratories Inc., Hercules, CA, USA), separated equal amounts of protein (30 mg) by SDS-PAGE and transferred them to polyvinylidene difluoride (PVDF) membranes Hybond P þ (Amersham Biosciences, Bucks, UK). Western blot analysis using specific antibodies was carried out as described (Baldi et al., 1995) . Blots were developed using horseradish peroxidase-conjugated secondary antibodies (Santa Cruz Biotechnology). Proteins were visualized by chemiluminescence detection (SuperSignal West Pico Chemiluminescent Substrate, Pierce, Rockford, IL, USA). Protein levels were quantified by densitometric analysis using the Scion Image Beta 4.02 software package (Scion Corporation, Frederick, MD, USA). The level of actin expression was used as a loading control.
BrdU incorporation assay
To examine proliferation of CGNPs, mice were injected intraperitoneally with BrdU in PBS (50 mg/g of body weight) (Sigma-Aldrich). After 1 h, they were euthanized and their tissues processed as described for histological analysis. Immunostaining of incorporated BrdU was performed on paraffin sections using BrdU Staining Kit (Zymed Laboratories Inc., San Francisco, CA, USA) according to the manufacturer's instructions.
Isolation of DNA and total RNA Genomic and tumor DNAs were extracted from tail and medulloblastomas by Wizard SV Genomic DNA Purification System (Promega Corporation, Madison, WI, USA). Total RNA was isolated from medulloblastomas using NucleoSpin Extract (Macherey-Nagel, Duren, Germany). Total RNA (2 mg) was reverse-transcribed using RETROscriptt (Ambion Inc., Austin, TX, USA) according to the manufacturer's instruction.
LOH at the Ptc1 locus in medulloblastomas LOH analysis at the Ptc1 locus was performed by amplification and sequencing of exon 23 -from genomic DNA and cDNA samples -of the murine Ptc1 gene, which holds a polymorphic site at position 4016. The primers used for the study were primer pair 8F/9R (Calzada-Wack et al., 2002) . Sequencing reactions were performed by means of dye terminator chemistry using a Big Dye Terminator Vers. 3.1 Sequencing Cycle kit and a 3730 DNA Analyzer (Applied Biosystems, Foster City, CA, USA). Loss of polymorphic sites in neoplastic compared to nonneoplastic tissue was considered LOH at the Ptc1 locus.
